Search results
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 1 day agoWhat do you get when you combine a low share price, an attractive valuation, better growth prospects than meet the eye, and a juicy dividend yield? My...
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Fisher Asset Management LLC
ETF DAILY NEWS· 7 days agoFisher Asset Management LLC raised its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 2.2% in the 4th quarter, HoldingsChannel reports. The fund ...
FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer - AstraZeneca (NASDAQ:AZN)
Benzinga· 7 days agoAstraZeneca plc’s AZN cancer drug, Imfinzi (durvalumab), in conjunction with standard chemotherapy,...
Wellington Management Group LLP Has $3.33 Billion Position in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 7 days agoWellington Management Group LLP decreased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 0.1% during the 4th quarter, according ...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 5 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
AstraZeneca's Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial - ...
Benzinga· 5 days agoTuesday, AstraZeneca Plc AZN announced topline data from the CAPItello-290 Phase 3 trial for Truqap...
One AstraZeneca Insider Raised Stake By 50% In Previous Year
Simply Wall St. via Yahoo Finance· 6 days agoViewing insider transactions for AstraZeneca PLC's (LON:AZN ) over the last year, we see that...
AstraZeneca’s breast cancer drug combination fails in late-stage trial
KFGO· 6 days ago(Reuters) - AstraZeneca said on Tuesday its breast cancer drug, Truqap, in combination with...
AstraZeneca Says Calquence/Chemo Combo Data Shows Additional 16.8 Months Without Disease Progression...
Benzinga· 7 days agoAstraZeneca Plc AZN released data from the ECHO Phase 3 trial of Calquence (acalabrutinib) plus...
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
Zacks via Yahoo Finance· 5 days agoAstraZeneca's (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients...